Use for interleukin-33 (IL33) and the IL33 receptor complex

Details for Australian Patent Application No. 2005215528 (hide)

Owner Schering Corporation

Inventors Oft, Martin; Kastelein, Robert A.; Schmitz, Jochen

Agent Griffith Hack

Pub. Number AU-B-2005215528

PCT Pub. Number WO2005/079844

Priority 60/545,730 17.02.04 US

Filing date 15 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 30 April 2009

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079844 Priority application(s): WO2005/079844

30 April 2009 Application Accepted

  Published as AU-B-2005215528

3 September 2009 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215546-Method of testing open services gateway initiative service platform and test tool using the method

2005215527-Methods of modulating IL-23 activity; related reagents